Expression of this protein correlated with a lower stage of the disease and a low level of MYCN amplification, whereas most of the c-kit-positive neuroblastomas represented differentiated (44.7%) or slightly differentiated (18.8%) tumors. Here, KIT is linked to neuroblastoma.